| Pharmaceutical active ingredients: |
| Doxorubicin Hydrochloride |
| Available forms, composition and doses of Doxopeg: |
| Injectable; Injection; Doxorubicin Hydrochloride 20 mg |
| Doxopeg medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01DB01 - Doxorubicin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Asofarma de MexicoRaffo Laboratorios |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Doxil | Doxorubicin Hydrochloride | ALZA; Ben Venue Laboratories; Johnson & Johnson; Ortho McNeil Pharmaceuticals |
| Doxo-Cell | Doxorubicin Hydrochloride | Cell Pharm; Stada |
| Doxolem | Doxorubicin Hydrochloride | Teva; CSC Pharmaceuticals Handels; Elder Pharmaceuticals; Lemery; Medicom International; Pharmaland 1982; Sicor Pharmaceuticals; Zodiac Produtos Farmaceuticos |
| Doxolem RU | Doxorubicin Hydrochloride | Teva |
| Doxomed | Doxorubicin Hydrochloride | Cipla |
| Doxorbin | Doxorubicin Hydrochloride | Bristol-Myers Squibb |
| Doxorubicin | Doxorubicin Hydrochloride | APP Pharmaceuticals |
| Doxorubicin | Doxorubicin Hydrochloride | Bedford Laboratories |
| Doxorubicin | Doxorubicin Hydrochloride | Biomedis Oncology |
| Doxorubicin | Doxorubicin Hydrochloride | Bryntsalov-A |